Hydroxyapatite (CaHA)
Hydroxyapatite is a widely studied biomaterial used in bone repair, coating development, and regenerative medicine.
View DetailsNanjing Junzhuo Biotechnology Co., Ltd. specializes in the R&D, manufacturing, and application support of advanced hydroxyapatite and bioceramic materials. We are committed to delivering highly stable and specialized material solutions for orthopedic reconstruction, medical aesthetic injectables, surface coatings, and translational research.
Hydroxyapatite is a widely studied biomaterial used in bone repair, coating development, and regenerative medicine.
View Details
Beta tricalcium phosphate (β-TCP) is a bioceramic for bone repair and regenerative applications with biocompatibility and controllable degradation.
View Details
Explore BCP, calcium silicate, and calcium sulfate hemihydrate for new bioceramic material development.
View DetailsWe support custom development around particle size, morphology, packaging, and application documentation from sample validation to project onboarding.
View DetailsNanjing Junzhuo Biotechnology Co., Ltd. focuses on the research, production, and custom development of high-end biomaterials, providing professional material solutions for customers worldwide.
About Junzhuo
The latest updates on company developments, technical articles, and industry content.
A Nihon University study used spray drying to prepare hollow HAp/boehmite particles, raising mean single-particle strength from about 0.6 to 8.5 MPa. Excess sol addition caused nozzle clogging and irregular particle shapes.
A roundup of industry announcements from October 19–25, 2026, covering HA–CaHA products, PCL microsphere fillers, sales performance, and market developments in Hong Kong, mainland China, and the UAE.
Ultrasound thickness, collagen histology, and formulation performance represent different levels of evaluation. Clear methods are needed to relate tissue findings to material properties.